Authors: DOGLIOTTI L DANESE S BERRUTI A ZOLA P BUNIVA T BOTTINI A RICHIARDI G MORO G FARRIS A BAU MG PORCILE G

Citation: L. Dogliotti et al., CISPLATIN, EPIRUBICIN, AND LONIDAMINE COMBINATION REGIMEN AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A PILOT-STUDY, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 333-338

Authors: BERRUTI A ZOLA P BUNIVA T BAU MG FARRIS A SAROBBA MG BOTTINI A TAMPELLINI M DURANDO A DESTEFANIS M MONZEGLIO C MORO G SUSSIO M PERRONI D DOGLIOTTI L

Citation: A. Berruti et al., PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER PATIENTS OBTAINING OBJECTIVE RESPONSE OR DISEASE STABILIZATION AFTER FIRST-LINE CHEMOTHERAPYWITH EPIRUBICIN - EVIDENCE FOR A POSITIVE EFFECT OF MAINTENANCE HORMONAL-THERAPY ON OVERALL SURVIVAL, Anticancer research, 17(4A), 1997, pp. 2763-2768

Authors: DOGLIOTTI L BERRUTI A BUNIVA T ZOLA P BAU MG FARRIS A SAROBBA MG BOTTINI A ALQUATI P DELTETTO F GOSSO P MONZEGLIO C MORO G SUSSIO M PERRONI D

Citation: L. Dogliotti et al., LONIDAMINE SIGNIFICANTLY INCREASES THE ACTIVITY OF EPIRUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Journal of clinical oncology, 14(4), 1996, pp. 1165-1172

Authors: KATSAROS D ZOLA P SINISTRERO G BERGAMINO T RUMORE A FERRERO A BAU MG SISMONDI P

Citation: D. Katsaros et al., WEEKLY CISPLATIN INDUCTION CHEMOTHERAPY IN HIGH-RISK CERVICAL-CANCER PATIENTS WITH BULKY TUMOR - A PHASE-II STUDY, International journal of oncology, 6(5), 1995, pp. 1033-1038

Authors: DOGLIOTTI L BERRUTI A BUNIVA T ZOLA P BAU MG FARRIS A SAROBBA MG BOTTINI A ALQUATI P DELTETTO F GOSSO P MONZEGLIO C MORO G SUSSIO M PERRONI D

Citation: L. Dogliotti et al., A RANDOMIZED COMPARISON OF HIGH-DOSE EPIRUBICIN VERSUS HIGH-DOSE EPIRUBICIN PLUS LONIDAMINE IN ADVANCED BREAST-CANCER PATIENTS - FIRST RESULTS FROM A COOPERATIVE GROUP-STUDY, International journal of oncology, 4, 1994, pp. 747-752

Authors: ZOLA P SCHNAPPER G KATSAROS D GENTA F BAU MG FERRERO AM GALLETTO L SISMONDI P

Citation: P. Zola et al., AVM (ADRIAMYCIN, VINBLASTINE, METHOTREXATE) NEOADJUVANT CHEMOTHERAPY IN ADVANCED OR INFLAMMATORY CARCINOMA OF THE BREAST, International journal of oncology, 3(5), 1993, pp. 869-872